


VIOLET Pharmaceuticals
Pharmaceutical Manufacturing • Barcelona, Catalonia, Spain • 1-10 Employees
Company overview
| Headquarters | Dr. Aiguader, 88, Barcelona, 08003, ES |
| NAICS | 3254 |
| Keywords | Nanotechnology, Gene Therapy, Biopharma, Pharma, Oncology, Immunotherapy, Drug Development, Immunology, Immune System, Immuno-Oncology, Gene Therapy, Immunotherapies, Metastasis, Deeptech, Adoptive Cell Transfer, Mrna Therapy, Antigen Presentation Machinery, Lymphocyte Enhancing Therapy, Immune Checkpoint Inhibitors, Immune Checkpoint Blockade, Tumor Immunogenicity |
| Employees | 1-10 |
Key Contact at VIOLET Pharmaceuticals
Toni Celià-Terrassa
Co-Founder of VIOLET Pharmaceuticals
About VIOLET Pharmaceuticals
VIOLET Pharmaceuticals is a preclinical stage biopharma company developing a First-in-Class mRNA therapy against metastatic cancers. The company develops nanotherapies improving immunotherapies’ efficiency and approved indications (e.g. Immune Checkpoints Inhibitors (ICI)) by increasing the whole Antigen Presentation Machinery (APM) in tumor cells. Our LCOR mRNA technology is backed by Top-Notch science published in leading journals such as Nature Cell Biology and Nature Cancer, and has a strong IP position (3 patents). We achieved radical complete responses of our LCOR mRNA NanoTherapy in combination with ICI in several breast cancer tumors and metastasis models. LCOR specifically modulates the whole APM which determines immune detection (tumor visibility) and immunotherapy response. There are currently no specific APM-modulating therapies on the market, only competitors with indirect APM modulation. Therefore, our patented gene therapy emerges as a critical therapeutic partner to make tumor cells visible and vulnerable to immunotherapies. VIOLET Pharmaceuticals : Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies
VIOLET Pharmaceuticals revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
VIOLET Pharmaceuticals has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
VIOLET Pharmaceuticals has never raised funding before.
Frequently asked questions
4.8
40,000 users



